Jennifer Dovey, PhD

Jennifer Dovey is Chief Scientific Officer at Triveni Bio where, in addition to being the founding employee, brings two decades of experience in drug discovery and development.  Previously, she served in roles of increasing responsibility at Amgen, Biogen and Celgene in oncology, fibrosis, aging and inflammation with a focus on epithelial disease biology.   Jennifer earned her PhD in Genetics from Harvard University and completed a postdoctoral fellowship at the Koch Institute for Integrative Cancer Research at MIT.